Clover Health Investments (CLOV) Receivables - Other (2021 - 2024)

Clover Health Investments (CLOV) has 4 years of Receivables - Other data on file, last reported at $15.0 million in Q3 2024.

• For the quarter ending Q3 2024, Receivables - Other rose 1.37% year-over-year to $15.0 million; the trailing twelve-month figure through Sep 2024 stood at $15.0 million (up 1.37% YoY), and the FY2023 full-year result was $16.7 million, down 29.37% from the prior year.
• Receivables - Other for Q3 2024 stood at $15.0 million, down from $21.2 million in the prior quarter.
• Across five years, Receivables - Other topped out at $82.7 million in Q2 2023 and bottomed at $13.7 million in Q1 2022.
• The 4-year median for Receivables - Other is $21.1 million (2021), against an average of $23.4 million.
• The widest annual swing landed in 2023, when Receivables - Other surged 470.94%; it then tumbled 74.33% in 2024.
• A 4-year view of Receivables - Other shows it stood at $14.3 million in 2021, then jumped by 65.21% to $23.6 million in 2022, then decreased by 29.37% to $16.7 million in 2023, then retreated by 10.22% to $15.0 million in 2024.
• The last three Receivables - Other figures came in at $15.0 million (Q3 2024), $21.2 million (Q2 2024), and $22.5 million (Q1 2024), per Business Quant data.

Peer Comparison